BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 30, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 10, 2017
View Archived Issues
Momenta Pharmaceuticals and CSL to develop Fc multimer proteins
Read More
Oncoprex shows positive interim results in phase II NSCLC study
Read More
Viamet Pharmaceuticals reports results from phase II studies of VT-1161
Read More
Ocera Therapeutics' oral OCR-002 shows favorable absorption and pharmacokinetics in phase I study
Read More
Minomic gives update on first-in-human study of MILGa
Read More
Novartis enters collaboration and option agreement with Ionis and Akcea
Read More
ProMIS Neurosciences names first lead product for Alzheimer's disease
Read More
FDA clears Sangamo's IND for hemophilia A gene therapy
Read More
Okogen enters agreement with Ora for development of OKG-0301
Read More
Afstyla approved in E.U. for hemophilia A
Read More
ARIAD enters into definitive agreement to be acquired by Takeda
Read More
Kite Pharma partners with Daiichi Sankyo for KTE-C19 in Japan
Read More
University College Dublin patents prostanoid TP antagonists
Read More
Pfizer describes BET protein inhibitors for cancer
Read More
KRICT reports PI3Kdelta inhibitors
Read More
Biorestorative Therapies submits IND for lead cell therapy candidate
Read More
Enzyvant Sciences enters agreement with Duke University for RVT-802
Read More
Phase II results for crizanlizumab as prevention of pain crises in patients with sickle cell disease
Read More
ThromboGenics initiates phase II trial of THR-317 for diabetic macular edema
Read More
Novel immune cell-mediated nanoparticle targeting strategy for the delivery of melanoma drug
Read More
Topline results from phase III study of glecaprevir/pibrentasvir for HCV in Japanese patients
Read More
Alexion Pharmaceuticals applies to expand indications of Soliris in E.U. and U.S.
Read More
FDA grants orphan drug designation to combination of TG-1101 and TGR-1202
Read More
Aralez Pharmaceuticals submits MAA for PA-10040 in E.U.
Read More
MabVax files IND in U.S. for MVT-1075
Read More
